Carregant...
An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications
On December 19, 2018, Altria announced an offer of $12.8 billion for Juul Labs, combining the largest U.S. cigarette manufacturer with the largest U.S. e-cigarette company. This deal is currently being challenged by the Federal Trade Commission (FTC). We consider the antitrust implications. We also...
Guardat en:
| Publicat a: | J Compet Law Econ |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318606/ https://ncbi.nlm.nih.gov/pubmed/34335858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/joclec/nhaa033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|